Merck & Co. Overview
Company: | Merck & Co. |
---|---|
CEO: | Mr. Robert M. Davis J.D. |
Founded: | Jan 1, 1891 |
Symbol: | MRK |
Exchange: | NYSE |
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
About |
Merck & Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences to jointly develop and commercialize long-acting treatments in HIV. Merck & Co. was founded in 1891 and is headquartered in Kenilworth, New Jersey. |
-
Ranking:
10 among 2858 companies
-
Address:
2000 Galloping Hill Road
-
City | State | Country:
Rahway | NJ |
US
-
Phone:
908 740 4000
- Website:
Merck & Co. (MRK)
- Stock Price
- Volume
- 1D
- 1W
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- 10Y
- ALL
Income Statement
Assets & Liabilities | Cash Flow
Ratios
Profitability
Valuation
Merck & Co.;MRK;https://bullfincher.io/logos/us/MRK.png;merck-co | 64168000000.00 |
---|---|
Eli Lilly and Company;LLY;https://bullfincher.io/logos/us/LLY.png;eli-lilly-and-company | 45042700000.00 |
Johnson & Johnson;JNJ;https://bullfincher.io/logos/us/JNJ.png;johnson-johnson | 88821000000.00 |
AbbVie;ABBV;https://bullfincher.io/logos/us/ABBV.png;abbvie | 56334000000.00 |
Amgen;AMGN;https://bullfincher.io/logos/us/AMGN.png;amgen | 33424000000.00 |
Frequently Asked Questions
When was Merck & Co. founded?
Merck & Co. was founded on Jan 1, 1891, which makes the company 134 years old.
Who is the CEO of Merck & Co.?
Mr. Robert M. Davis J.D. is the CEO of Merck & Co..
What industry and sector is Merck & Co. in?
Merck & Co. operates in the Drug Manufacturers - General industry and the Healthcare sector.
What are Merck & Co.'s CIK, SIC, and ISIN codes?
- CIK (Central Index Key): 0000310158
- SIC (Standard Industrial Classification): 2834
- ISIN (International Securities Identification Number): US58933Y1055
How many employees does Merck & Co. have?
Merck & Co. has 75,000 employees.
What is the revenue of Merck & Co.?
In fiscal year 2024, Merck & Co. generated a revenue of $64.17 Billion.
What is the net income of Merck & Co.?
In fiscal year 2024, Merck & Co. reported a net income of $17.12 Billion.
What is Merck & Co.'s biggest product segment?
Pharmaceutical segment is Merck & Co.'s biggest product segment, representing 90.71% of its total revenue.
When was Merck & Co. listed on the stock exchange?
Merck & Co. went public on Jan 13, 1978, through its Initial Public Offering (IPO), and it has been 47 years since then.
What is the ticker symbol of Merck & Co., and where is it listed?
Merck & Co.'s ticker symbol is MRK, and the company is listed on the NYSE stock market exchange.
What is Merck & Co.'s current stock price?
Merck & Co.'s current stock price is $77.14 as of Jun 3, 2025.
What is Merck & Co.'s ranking in the world?
Ranked #10among 2,858 companies based on market cap.
Who are the top competitors of Merck & Co.?
Competitors of Merck & Co. include Eli Lilly and Company, Johnson & Johnson and AbbVie, and more.